A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes R Candido, JM Forbes, MC Thomas, V Thallas, RG Dean, WC Burns, ... Circulation research 92 (7), 785-792, 2003 | 643 | 2003 |
Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes MI Constantino, L Molyneaux, F Limacher-Gisler, A Al-Saeed, C Luo, ... Diabetes care 36 (12), 3863-3869, 2013 | 471 | 2013 |
Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers Y Liu, D Min, T Bolton, V NUBe, SM Twigg, DK Yue, SV McLennan Diabetes care 32 (1), 117-119, 2009 | 469 | 2009 |
Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers CR Ban, SM Twigg Vascular health and risk management 4 (3), 575-596, 2008 | 408 | 2008 |
Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E–deficient mice R Candido, KA Jandeleit-Dahm, Z Cao, SP Nesteroff, WC Burns, ... Circulation 106 (2), 246-253, 2002 | 353 | 2002 |
Connective tissue growth factor plays an important role in advanced glycation end product–induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal … WC Burns, SM Twigg, JM Forbes, J Pete, C Tikellis, V Thallas-Bonke, ... Journal of the American Society of Nephrology 17 (9), 2484-2494, 2006 | 341 | 2006 |
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial JR Petrie, N Chaturvedi, I Ford, MCGJ Brouwers, N Greenlaw, T Tillin, ... The lancet Diabetes & endocrinology 5 (8), 597-609, 2017 | 325 | 2017 |
E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-β B Wang, M Herman-Edelstein, P Koh, W Burns, K Jandeleit-Dahm, ... Diabetes 59 (7), 1794-1802, 2010 | 317 | 2010 |
Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit SM Twigg, RC Baxter Journal of Biological Chemistry 273 (11), 6074-6079, 1998 | 293 | 1998 |
Diabetes and nonalcoholic fatty liver disease: a pathogenic duo KH Williams, NA Shackel, MD Gorrell, SV McLennan, SM Twigg Endocrine reviews 34 (1), 84-129, 2013 | 291 | 2013 |
Connective tissue growth factor and cardiac fibrosis after myocardial infarction RG Dean, LC Balding, R Candido, WC Burns, Z Cao, SM Twigg, ... Journal of Histochemistry & Cytochemistry 53 (10), 1245-1256, 2005 | 291 | 2005 |
Thymic carcinoids in multiple endocrine neoplasia type 1 BT Teh, J Zedenius, S Kytölä, B Skogseid, J Trotter, H Choplin, S Twigg, ... Annals of Surgery 228 (1), 99-105, 1998 | 273 | 1998 |
An inverse relationship between age of type 2 diabetes onset and complication risk and mortality: the impact of youth-onset type 2 diabetes AH Al-Saeed, MI Constantino, L Molyneaux, M D’Souza, ... Diabetes care 39 (5), 823-829, 2016 | 269 | 2016 |
Advanced glycosylation end products up-regulate connective tissue growth factor (insulin-like growth factor-binding protein-related protein 2) in human fibroblasts: a potential … SM Twigg, MM Chen, AH Joly, SD Chakrapani, J Tsubaki, HS Kim, Y Oh, ... Endocrinology 142 (5), 1760-1769, 2001 | 219 | 2001 |
Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine SM Twigg, Z Cao, SV McLennan, WC Burns, G Brammar, JM Forbes, ... Endocrinology 143 (12), 4907-4915, 2002 | 207 | 2002 |
Screening for celiac disease in type 1 diabetes: a systematic review A Pham-Short, KC Donaghue, G Ambler, H Phelan, S Twigg, ME Craig Pediatrics 136 (1), e170-e176, 2015 | 201 | 2015 |
Prediabetes: a position statement from the australian diabetes society and australian diabetes educators association SM Twigg, MC Kamp, TM Davis, EK Neylon, JR Flack Medical journal of Australia 186 (9), 461-465, 2007 | 194 | 2007 |
Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic … SV McLennan, XY Wang, V Moreno, DK Yue, SM Twigg Endocrinology 145 (12), 5646-5655, 2004 | 192 | 2004 |
Integrated actions of transforming growth factor-β1 and connective tissue growth factor in renal fibrosis W Qi, S Twigg, X Chen, TS Polhill, P Poronnik, RE Gilbert, CA Pollock American Journal of Physiology-Renal Physiology 288 (4), F800-F809, 2005 | 190 | 2005 |
Timing is everything: age of onset influences long-term retinopathy risk in type 2 diabetes, independent of traditional risk factors J Wong, L Molyneaux, M Constantino, SM Twigg, DK Yue Diabetes care 31 (10), 1985-1990, 2008 | 160 | 2008 |